We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
ICHNO 2026
Programme
HPV or EBV related cancers
19 March 2026 - 21 March 2026
Seville, Spain
ICHNO 2026
Session
HPV or EBV related cancers
Session Type:
Poster
Journey:
Add to
My Programme
Impact of Smoking Status and Pack-Years on Outcomes in HPV-Associated Oropharyngeal Carcinoma Treated with Definitive (Chemo)Radiotherapy
Shao Hui Huang
,
Canada
Presentation Number:
-82
Highly-Multiplex Detection of Plasma Cell-Free High-Risk Human Papillomavirus DNA for Rare Genotypes
Janita Basit
,
Ireland
Presentation Number:
-83
Relationship between Epstein Barr Virus and nasopharyngeal cancer as a predictor of treatment response and recurrence
Cristian Arias
,
Spain
Presentation Number:
-195
Longitudinal Plasma ctDNA and Pathological Response Correlate with Clinical Outcomes in Oropharyngeal Cancer: Interim Analysis from the NECTORS Trial
Nivedita Kaorey
,
Canada
Presentation Number:
-252
Circulating tumor HPV DNA in HPV-associated oropharyngeal squamous cell carcinoma as a marker of recurrence: A retrospective cohort of 224 patients
Iwona Jabłońska
,
Poland
Presentation Number:
-258
Medial retropharyngeal lymph node involvement and recurrence rate in patients with nasopharyngeal carcinoma – a German multicenter analysis
Justus Kaufmann
,
Germany
Presentation Number:
-300
DNA-methylation as diagnostic and prognostic biomarker for oropharyngeal cancer – a proof-of-concept study
Wouter Huvenne
,
Belgium
Presentation Number:
-364
Comparison of NGS-based (HPV-Detect) and ddPCR plasma HPV-DNA assays for treatment response estimation in head and neck cancer in the INOVATE study
Shreerang Bhide
,
United Kingdom
Presentation Number:
-371
18F-FDG PET/CT dynamic Biomarkers in Metastatic Nasopharyngeal Carcinoma with PD-1 inhibitor
Beibei Xiao
,
China
Presentation Number:
-378
Characterization of the Intratumoral Microbiota in Non-Endemic EBV-Related Nasopharyngeal Carcinoma
Deborah Lenoci
,
Italy
Presentation Number:
-407
Phase 2 Trial of Ozuriftamab Vedotin (Oz-V), a conditionally binding ROR2-targeting ADC, in Patients with Treatment Refractory HPV+ OPSCC
Kyechin Chen
,
USA
Presentation Number:
-444
Postoperative cfHPV DNA Kinetics as a Potential Biomarker for Adjuvant Treatment Decision-Making in HPV-Positive OPSCC.
Radka Lohynska
,
Czech Republic
Presentation Number:
-475
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.